These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9605497)

  • 1. Central administration of a nitric oxide synthase inhibitor causes pressor responses via the sympathetic nervous system and the renin-angiotensin system in Wistar rats.
    Moriguchi S; Ohzuru N; Koga N; Honda K; Saito R; Takano Y; Kamiya H
    Neurosci Lett; 1998 Apr; 245(2):109-12. PubMed ID: 9605497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostaglandin, endothelin and sympathetic nervous system on the L-NAME-induced pressor responses in spontaneously hypertensive rats.
    Salas N; Terrell ML; Summy-Long JY; Kadekaro M
    Brain Res; 2003 Sep; 983(1-2):162-73. PubMed ID: 12914977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular regulation by L-arginine in the brain of rats: role of the brain renin-angiotensin system and nitric oxide.
    Nishimura M; Takahashi H; Nanbu A; Sakamoto M; Yoshimura M
    Am J Hypertens; 1997 Apr; 10(4 Pt 1):389-96. PubMed ID: 9128204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
    K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
    J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible participation of spinal nitric oxide in the control of the blood pressure in anesthetized rats.
    del Carmen García M; Celuch SM; Adler-Graschinsky E
    Brain Res; 1997 Aug; 764(1-2):67-74. PubMed ID: 9295194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
    Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
    Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
    Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.
    Pechánová O; Dobesová Z; Cejka J; Kunes J; Zicha J
    J Hypertens; 2004 Jan; 22(1):167-73. PubMed ID: 15106808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain ANG II and prostaglandins mediate the pressor response after central blockade of nitric oxide synthase.
    Liu H; Terrell ML; Summy-Long JY; Kadekaro M
    Brain Res; 1998 Mar; 785(2):317-28. PubMed ID: 9518669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia.
    Kunes J; Dobesová Z; Zicha J
    Clin Sci (Lond); 2002 Mar; 102(3):269-77. PubMed ID: 11869167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of nitric oxide in the spinal cord in cardiovascular regulation in rats.
    Koga N; Takano Y; Honda K; Saito R; Kamiya H
    Neurosci Lett; 1999 Jun; 267(3):173-6. PubMed ID: 10381004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
    Eshima K; Hirooka Y; Shigematsu H; Matsuo I; Koike G; Sakai K; Takeshita A
    Hypertension; 2000 Aug; 36(2):259-63. PubMed ID: 10948087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats.
    Nakata T; Takeda K; Harada S; Oguni A; Hatta T; Kawa T; Itoh H; Sasaki S; Nakagawa M
    Hypertens Res; 2001 Jan; 24(1):39-45. PubMed ID: 11213029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
    Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
    J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
    Lee BH; Shin HS
    Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nitric oxide in the development of neurogenic pulmonary edema in spinal cord-injured rats: the effect of preventive interventions.
    Sedy J; Zicha J; Kunes J; Hejcl A; Syková E
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1111-7. PubMed ID: 19675280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin.
    el Karib AO; Sheng J; Betz AL; Malvin RL
    Clin Exp Hypertens; 1993 Sep; 15(5):819-32. PubMed ID: 7691341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of alpha-adrenoceptor-mediated pressor responses by NG-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats.
    Guc MO; Furman BL; Paratt JR
    Eur J Pharmacol; 1992 Nov; 224(1):63-9. PubMed ID: 1280596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
    Nafrialdi N; Jover B; Mimran A
    J Cardiovasc Pharmacol; 1994 May; 23(5):765-71. PubMed ID: 7521459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.